These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7390672)

  • 1. The influence of renal function on the elimination kinetics of sulbenicillin in man.
    Montanari A; Borghi L; Canali M; Coruzzi P; Novarini A; Borghetti A
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(5):225-8. PubMed ID: 7390672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of renal function on plasma levels and urinary excretion of acebutolol and its main N-acetyl metabolite.
    Kirch W; Köhler H; Berggren G; Braun W
    Clin Nephrol; 1982 Aug; 18(2):88-94. PubMed ID: 7140021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulbenicillin: pharmacokinetics and penetration into bronchial secretion in elderly patients.
    Ripa S; Mignini F; Patrizi I; Ferrante L; Prenna M; Falcioni E
    Chemioterapia; 1987 Aug; 6(4):277-81. PubMed ID: 3652279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics in renally impaired subjects of NXY-059, a nitrone-based, free-radical trapping agent developed for the treatment of acute stroke.
    Strid S; Borgå O; Edenius C; Jostell KG; Odergren T; Weil A
    Eur J Clin Pharmacol; 2002 Sep; 58(6):409-15. PubMed ID: 12242600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacokinetics of nimodipine in normal and impaired renal function.
    Kirch W; Rämsch KD; Dührsen U; Ohnhaus EE
    Int J Clin Pharmacol Res; 1984; 4(5):381-4. PubMed ID: 6519852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic profile of benoxaprofen in subjects with normal and impaired renal function, prediction of multiple-dose kinetics.
    Brogard JM; Comte F; Madon M; Spach MO
    Eur J Rheumatol Inflamm; 1982; 5(2):113-23. PubMed ID: 7084275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of the new broad spectrum penicillin CP-33994-2.
    Bergan T; Brodwall EK; Orjavik O
    Arzneimittelforschung; 1980; 30(7):1144-7. PubMed ID: 7191297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variability of ceftriaxone pharmacokinetics in hospitalized patients with severe infections.
    Joos B; Luethy R; Muehlen E; Siegenthaler W
    Am J Med; 1984 Oct; 77(4C):59-62. PubMed ID: 6093521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics of indoprofen in patients with renal insufficiency (a preliminary report).
    Wibell L; Nilsson P; Lindström B
    Eur J Rheumatol Inflamm; 1981; 4(1):16-21. PubMed ID: 7341276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biopharmaceutical studies on pyridinolcarbamate. V. Effect of repeated administration of pyridinolcarbamate on the renal excretion of sulbenicillin in rabbits.
    Suenaga A; Nakagawa H; Huang MT; Imamura Y; Otagiri M; Ichibagase H
    Acta Pharm Suec; 1985; 22(1):45-52. PubMed ID: 4024967
    [No Abstract]   [Full Text] [Related]  

  • 11. [Update on antibiotic therapy. 16) Sulbenicillin].
    Di Nola F
    Minerva Med; 1983 Apr; 74(18):1073-6. PubMed ID: 6678394
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacokinetics of ceftazidime in normal and impaired renal function.
    Höffler D; Koeppe P; Williams KJ
    Arzneimittelforschung; 1984; 34(1):72-6. PubMed ID: 6367755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Studies on the intravenous administration of sulbenicillin (author's transl)].
    Kato Y; Saito A; Yajima O; Tomizawa M; Nakayma I
    Jpn J Antibiot; 1976 Apr; 29(4):358-65. PubMed ID: 778428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cephacetrile--application of pharmacokinetic data to dosage determination.
    Brogard JM; Dorner M; Brandt C; Lavillaureix J
    Int J Clin Pharmacol Biopharm; 1976 Apr; 13(3):168-76. PubMed ID: 950258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Benoxaprofene: pharmacokinetic profile in the normal subject and patients with renal insufficiency; evaluation of anticipated serum levels].
    Brogard JM; Audhuy B; Spach MO
    Schweiz Med Wochenschr; 1981 Feb; 111(6):197-201. PubMed ID: 7221526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of fleroxacin in renal impairment.
    Weidekamm E
    Am J Med; 1993 Mar; 94(3A):70S-74S. PubMed ID: 8452185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Electrolyte and acid-base balance disorders in advanced chronic kidney disease].
    Alcázar Arroyo R
    Nefrologia; 2008; 28 Suppl 3():87-93. PubMed ID: 19018744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of renal function on recainam pharmacokinetics and pharmacodynamics.
    Cheng JW; Charland SL; Goldfarb S; Spinler SA
    Clin Pharmacol Ther; 1995 May; 57(5):492-8. PubMed ID: 7768071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of cefapirin in patients with normal and impaired renal functions.
    Bergan T; Orjavik O; Brodwall EK
    Arzneimittelforschung; 1981; 31(10):1773-6. PubMed ID: 7198453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of rofecoxib on the glomerular filtration rate, proteinuria and the renin-angiotensin-aldosterone system in elderly subjects with chronic renal impairment.
    Horackova M; Schück O; Komers R; Charvat J; Teplan V; Kvapil M
    Int J Clin Pharmacol Ther; 2005 Sep; 43(9):413-9. PubMed ID: 16163893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.